Chapter 29: Organic Synthesis
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Chapter 29, "Organic synthesis," delves into advanced organic chemistry techniques, focusing particularly on the critical role of chirality in the development of modern pharmaceuticals and the strategic planning of complex chemical reactions. The process of designing new drugs often begins with molecular modelling, utilizing computational methods and structural analysis, such as X-ray crystallography used to determine the shape of enzymes like HIV protease, which drastically reduces the time and expense of finding molecules that effectively bind to and block specific receptor sites. A majority of new medicinal compounds contain at least one chiral centre—a carbon atom bonded to four distinct groups—resulting in two non-superimposable mirror images called enantiomers. Although enantiomers share identical physical and chemical properties, they differ significantly in their biological activity and potential pharmacological effect. When drugs are synthesized using conventional methods, they typically produce a 50:50 blend, known as a racemic mixture. However, only one specific enantiomer is usually beneficial, exhibiting better therapeutic activity, while the other isomer might be ineffective or even cause severe side-effects (such as liver damage or blindness in specific drug examples). Therefore, the pharmaceutical industry aims to produce single pure enantiomers to reduce patient dosage, increase potency, and minimize legal risks associated with adverse reactions. To achieve this purity, chemists employ several strategies: optical resolution involves synthesizing the racemic mixture first and then separating the enantiomers using a chiral auxiliary and physical techniques like fractional crystallization, sometimes utilizing safer solvents such as supercritical carbon dioxide. Alternative, more efficient methods include utilizing the chiral pool—naturally occurring, optically active starting materials (like amino acids or carbohydrates) already in the desired configuration—or, ideally, employing chiral catalysts or specialized enzymes. These catalytic approaches promote stereoselectivity, ensuring only the correct enantiomer is formed, and are considered "greener" synthetic processes. Finally, the chapter covers the design of multi-stage synthetic routes, where research chemists typically work backward (retrosynthesis) from the desired final compound to readily available raw materials. Successful synthesis requires a deep understanding of reactions involving various functional groups, including addition, condensation, hydrolysis, and substitution. For increasing the carbon chain length, the nitrile functional group can be introduced using halogenoalkanes, and the resulting nitrile molecule (RC-N) can then be further converted to a carboxylic acid or an amine. The aim is always to complete the synthesis in the fewest possible steps, as material is lost at every stage.